|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date31 Dec 1942 |
Clinical Trial Randomized, Placebo-controlled, Using Dapsone as a Neuroprotector During Acute Ischemia Stroke
The main purpose of the study is to get information about the safety and efficacy of treatment with Dapsone to prevent the disability after ischemic Stroke, in patients diagnosed with anterior territory brain infarct.
100 Clinical Results associated with Cidat Sa De Cv
0 Patents (Medical) associated with Cidat Sa De Cv
100 Deals associated with Cidat Sa De Cv
100 Translational Medicine associated with Cidat Sa De Cv